Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 3, 2006, Pages

  Fitch, Richard M ^a,b   Rutledge, John C ^b   Wang, Yi Xin ^a   Powers, Andrew F ^b   Tseng, Jih Lie ^a   Clary, Taegan ^a   Rubanyi, Gabor M ^a  

^a BAYER AG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood pressure; Collagen; Elastin; N nitro L arginine methyl ester; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN II; COLLAGEN; ELASTIN; N(G) NITROARGININE METHYL ESTER; PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA DISEASE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG POTENTIATION; DRY WEIGHT; EXTRACELLULAR MATRIX; MALE; MOUSE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; PULSE WAVE; RIGIDITY; VASCULAR SMOOTH MUSCLE; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; ELASTICITY; MECHANICAL STRESS; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; VASCULAR RESISTANCE;

ANGIOTENSIN II; ANIMALS; AORTA; DRUG COMBINATIONS; DRUG SYNERGISM; ELASTICITY; MALE; MICE; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STRESS, MECHANICAL; VASCULAR RESISTANCE;

EID: 33645728559     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00327.2005     Document Type: Article

References (47)

1. Bank AJ, Kaiser DR, Rajala S, and Cheng A. In vivo human brachial artery elastic mechanics: effects of smooth muscle relaxation. Circulation 100: 41-47, 1999.
2. Blacher J, Asmar R, Djane S, London GM, and Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33: 1111-1117, 1999.
3. Bruel A, Ortoft G, and Oxlund H. Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. Atherosclerosis 140: 135-145, 1998.
4. Bruel A and Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation end products of the rat aorta in relation to age. Atherosclerosis 127: 155-165, 1996.
5. Dzau VJ. Mechanism of protective effects of ACE inhibition on coronary artery disease. Eur Heart J 19, Suppl J: J2-J6, 1998.
6. Elhage R, Bayard F, Richard V, Holvoet P, Duverger N, Fievet C, and Arnal JF. Prevention of fatty streak formation of 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 96: 3048-3052, 1997.
7. Eriksson A, Greiff E, Loupas T, Persson M, and Pesque P. Arterial pulse wave velocity with tissue Doppler imaging. Ultrasound Med Biol 28: 571-580, 2002.
8. Fitch RM, Vergona R, Sullivan ME, and Wang YX. Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res 51: 351-358, 2001.
9. Geisterfer AA, Peach MJ, and Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749-756, 1988.
10. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
11. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, and Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991.
12. Hartley CJ, Reddy AK, Madala S, Martin-McNulty B, Vergona R, Sullivan ME, Halks-Miller M, Taffet GE, Michael LH, Entman ML, and Wang YX. Hemodynamic changes in apolipoprotein E-knockout mice. Am J Physiol Heart Circ Physiol 279: H2326-H2334, 2000.
13. Jesmin S, Sakuma I, Hattori Y, and Kitabatake A. Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats. Arterioscler Thromb Vasc Biol 23: 2021-2026, 2003.
14. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, and Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 9: 17-22, 1991.
15. Kauser K, da Cunha V, Fitch R, Mallari C, and Rubanyi GM. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 278: H1679-H1685, 2000.
16. Kolpakov V, Gordon D, and Kulik TJ. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 76: 305-309, 1995.
17. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, and Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37: 1236-1241, 2001.
18. Manzoli A, Andreotti F, Leone AM, Sperti G, Zecchi P, and Di Sciascio G. Vascular and haemostatic gene polymorphisms associated with non-fatal myocardial infarction: a critical review. Ital Heart J 1: 184-193, 2000.
19. Meaume S, Benetos A, Henry OF, Rudnichi A, and Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 21: 2046-2050, 2001.
20. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: 58e-65e, 2002.
21. Movat HZ. Demonstration of all connective tissue elements in a single section; pentachrome stains. AMA Arch Pathol 60: 289-295, 1955.
22. Myers PR and Tanner MA. Vascular endothelial cell regulation of extracellular matrix collagen: role of nitric oxide. Arterioscler Thromb Vasc Biol 18: 717-722, 1998.
23. Naftilan AJ, Pratt RE, Eldridge CS, Lin HL, and Dzau VJ. Angiotensin II induces c-fos expression in smooth muscle via transcriptional control. Hypertension 13: 706-711, 1989.
24. Neter J, Kutner MH, Nachtsheim C, and Wasserman W. Applied Linear Statistical Models. Boston, MA: McGraw-Hill, 1996.
25. Nichols WW and O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretic, Experimental, and Clinical Principles. London: Arnold, 1998.
26. Oxlund H. Changes in the biomechanical properties of skin and aorta induced by corticotrophin treatment. Acta Endocrinol 94: 132-137, 1980.
27. Paul R. The effects of isoproterenol and ouabain on oxygen consumption, lactate production, and the activation of phosphorylase in coronary artery smooth muscle. Circ Res 52: 683-690, 1983.
28. Raij L. Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction. Hypertension 37: 767-773, 2001.
29. Rizvi MAD and Myers PR. Nitric oxide modulates basal and endothelin-induced coronary artery vascular smooth muscle cell proliferation and collagen levels. J Mol Cell Cardiol 29: 1779-1789, 1997.
30. Safar ME and Laurent P. Pulse pressure and arterial stiffness in rats: comparison with humans. Am J Physiol Heart Circ Physiol 285: H1363-H1369, 2003.
31. Safar ME, Levy BI, and Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107: 2864-2869, 2003.
32. Safar ME, London GM, and Plante GE. Arterial stiffness and kidney function. Hypertension 43: 163-168, 2004.
33. Sims TJ, Rasmussen LM, Oxlund H, and Bailey AJ. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 39: 946-951, 1996.
34. Stegemann H and Stalder K. Determination of hydroxyproline. Clin Chim Acta 18: 267-273, 1967.
35. Symons JD, Mullick AE, Ensunsa JL, Ma AA, and Rutledge JC. Hyperhomocysteinemia evoked by folate depletion: effects on coronary and carotid arterial function. Arterioscler Thromb Vasc Biol 22: 772-780, 2002.
36. Tham DM, Martin-McNulty B, Wang YX, Da Cunha V, Wilson DW, Athanassious CN, Powers AF, Sullivan ME, and Rutledge JC. Angiotensin II injures the arterial wall causing increased aortic stiffening in apolipoprotein E-deficient mice. Am J Physiol Regul Integr Comp Physiol 283: R1442-R1449, 2002.
37. Thomas J, Elsden DF, and Partridge SM. Partial structure of two major degradation products from the cross-linkages in elastin. Nature 200: 651-652, 1963.
38. 2+ channels. Am J Physiol Heart Circ Physiol 283: H247-H253, 2002.
39. Virdis A, Neves MF, Amiri F, Touyz RM, and Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22: 535-542, 2004.
40. Wang HD, Johns DG, Xu S, and Cohen RA. Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. Am J Physiol Heart Circ Physiol 282: H1697-H1702, 2002.
41. Wang YX and Fitch RM. Vascular stiffness: measurements, mechanisms and implications. Curr Vasc Pharmacol 2: 379-384, 2004.
42. Wang YX, Halks-Miller M, Vergona R, Sullivan ME, Fitch R, Mallari C, Martin-McNulty B, da Cunha V, Freay A, Rubanyi GM, and Kauser K. Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 278: H428-H434, 2000.
43. Wang YX, Martin-McNulty B, Freay AD, Sukovich DA, Halks-Miller M, Li WW, Vergona R, Sullivan ME, Morser J, Dole WP, and Deng GG. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 159: 1455-1464, 2001.
44. Weiss D, Sorescu D, and Taylor WR. Angiotensin II and atherosclerosis. Am J Cardiol 87: 25C-32C, 2001.
45. Wight TN. Arterial wall. In: Extracellular Matrix, edited by Comper WD. Amsterdam, The Netherlands: Harwood Academic, 1996, p. 476.
46. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, and Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 105: 213-217, 2002.
47. Yan C, Kim D, Aizawa T, and Berk BC. Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator. Arterioscler Thromb Vasc Biol 23: 26-36, 2003.